Ibnsina Pharma posts strong consolidated results for 2024: EGX-listed pharma distributor Ibnsina Pharma's bottom line rose 188% y-o-y to record EGP 614.5 mn in 2024, according to the company’s latest earnings release (pdf). Revenues came in at EGP 55.8 bn, marking a 64.5% y-o-y increase for the year.

(Tap or click the headline above to read this story with all of the links to our background as well as external sources.)

More than just numbers: Ibnsina Pharma currently holds a 30.8% share of the national pharma distribution market. It also led Egypt’s pharma and hospitals sector last year and ranked first in public and private hospitals.

What they said: “The gain in market share and acceleration of pharma product re-pricing — which is expected to be more evident in the market in 2025 and 2026 — are key drivers supporting future growth,” the co-CEOs said in the release. “Looking ahead, we are confident that the investments we have made in both our people and technology will enable us to continue leading the market, driving efficiency, and meeting the ever-evolving needs of our stakeholders.”

UNITED BANK REPORTS 2024 EARNINGS-

United Bank saw its net income after tax jump 63% y-o-y in 2024, to record EGP 2.8 bn, according to a disclosure (pdf) to the EGX. The bank’s net interest income rose to EGP 4.8 bn, marking a 47% y-o-y increase.

Tags: